Michael Hejna
Impact in
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
-
- Gastric Cancer Management and Outcomes
- Oral health in cancer treatment
- Gallbladder and Bile Duct Disorders
Papers in
- Oncology 62
- HER2/EGFR in Cancer Research 13
- Colorectal Cancer Treatments and Studies 13
- Cancer Treatment and Pharmacology 12
- Pancreatic and Hepatic Oncology Research 11
-
- Gastric Cancer Management and Outcomes 35
- Lung Cancer Treatments and Mutations 11
- Co-authors
- Markus Raderer (42 shared papers)Christoph Zielinski (15 shared papers)Manuela Schmidinger (7 shared papers)Werner Scheithauer (33 shared papers)Wolfgang J. Köstler (9 shared papers)Stefan Wöhrer (9 shared papers)C. Zielinski (4 shared papers)Gabriela Kornek (20 shared papers)
- Journals
- Annals of Oncology (10 papers)Journal of Clinical Oncology (10 papers)British Journal of Cancer (9 papers)Cancer (7 papers)European Journal of Cancer (7 papers)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Michael Hejna
104 papers receiving 3.7k citations
Michael Hejna's Hit Papers
Peers
Comparison fields: 5 of 117
- Oncology 1.9k
- Pulmonary and Respiratory Medicine 1.7k
- Otorhinolaryngology 194
- Gastroenterology 174
- Pathology and Forensic Medicine 475
Countries citing papers authored by Michael Hejna
This map shows the geographic impact of Michael Hejna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hejna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hejna more than expected).
Fields of papers citing papers by Michael Hejna
This network shows the impact of papers produced by Michael Hejna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hejna. The network helps show where Michael Hejna may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Hejna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma Hit paper breakdown → | 2008 | 486 |
| 2 | 2001 | 266 | |
| 3 | 1999 | 199 | |
| 4 | 2004 | 149 | |
| 5 | 1997 | 132 | |
| 6 | 2005 | 128 | |
| 7 | 2002 | 125 | |
| 8 | 2004 | 118 | |
| 9 | 1999 | 114 | |
| 10 | 2002 | 106 | |
| 11 | 1998 | 105 | |
| 12 | 2011 | 91 | |
| 13 | 2006 | 85 | |
| 14 | 2006 | 73 | |
| 15 | 1999 | 72 | |
| 16 | Palliative chemotherapy for recurrent and metastatic esophageal cancer. | 2007 | 63 |
| 17 | 2000 | 52 | |
| 18 | 2001 | 51 | |
| 19 | 1999 | 50 | |
| 20 | 2000 | 50 |
About Michael Hejna
Michael Hejna is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Epidemiology and Pathology and Forensic Medicine, having authored 107 papers that have together received 3.8k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (35 papers), Esophageal Cancer Research and Treatment (19 papers), HER2/EGFR in Cancer Research (13 papers), Colorectal Cancer Treatments and Studies (13 papers), Cancer Treatment and Pharmacology (12 papers), Neuroendocrine Tumor Research Advances (12 papers), Lung Cancer Treatments and Mutations (11 papers) and Pancreatic and Hepatic Oncology Research (11 papers). The work is most often cited by research in Oncology (1.9k citations), Pulmonary and Respiratory Medicine (1.7k citations), Otorhinolaryngology (194 citations), Gastroenterology (174 citations) and Pathology and Forensic Medicine (475 citations). Michael Hejna has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Markus Raderer, Christoph Zielinski, Manuela Schmidinger, Werner Scheithauer, Wolfgang J. Köstler, Stefan Wöhrer, C. Zielinski, Gabriela Kornek, C. Wenzel and Ursula Vogl. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, British Journal of Cancer, Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.